Cereijido M, Jimenez L, Hinojosa L, Castillo A, Martinez-Rendon J, Ponce A
Int J Mol Sci. 2022; 23(21).
PMID: 36362049
PMC: 9655981.
DOI: 10.3390/ijms232113257.
Pogoda J, Gross N, Arakaki X, Fonteh A, Cowan R, Harrington M
Headache. 2016; 56(4):688-98.
PMID: 27016121
PMC: 4836999.
DOI: 10.1111/head.12792.
Hodes A, Lichtstein D
Front Endocrinol (Lausanne). 2014; 5:201.
PMID: 25506340
PMC: 4246887.
DOI: 10.3389/fendo.2014.00201.
Wansapura A, Lasko V, Lingrel J, Lorenz J
Am J Physiol Heart Circ Physiol. 2010; 300(1):H347-55.
PMID: 20952666
PMC: 3023246.
DOI: 10.1152/ajpheart.00625.2010.
Kimura T, Allen P, Nairn A, Caplan M
Mol Biol Cell. 2007; 18(11):4508-18.
PMID: 17804821
PMC: 2043564.
DOI: 10.1091/mbc.e06-08-0711.
Endogenous digitalis-like Na+, K+-ATPase inhibitors, and brain function.
Lichtstein D, Rosen H
Neurochem Res. 2001; 26(8-9):971-8.
PMID: 11699949
DOI: 10.1023/a:1012340702763.
How many endobains are there?.
Rodriguez de Lores Arnaiz G
Neurochem Res. 2000; 25(9-10):1421-30.
PMID: 11059812
DOI: 10.1023/a:1007620918408.
Ouabain-like activity in human cerebrospinal fluid.
Halperin J, Schaeffer R, Galvez L, Malave S
Proc Natl Acad Sci U S A. 1983; 80(19):6101-4.
PMID: 6310614
PMC: 534368.
DOI: 10.1073/pnas.80.19.6101.
Membrane potential changes induced by the ouabain-like compound extracted from mammalian brain.
Lichtstein D, Samuelov S
Proc Natl Acad Sci U S A. 1982; 79(5):1453-6.
PMID: 6280183
PMC: 345991.
DOI: 10.1073/pnas.79.5.1453.
Neural regulation on the active sodium-potassium transport in hypokalaemic rat skeletal muscles.
Akaike N, Hirata A, Kiyohara T, Oyama Y
J Physiol. 1983; 341:245-55.
PMID: 6137559
PMC: 1195333.
DOI: 10.1113/jphysiol.1983.sp014804.
Species-dependent isoenzyme subtypes of membrane-bound cyclic AMP-dependent protein kinase in highly purified cardiac sarcolemma.
CHURCH J, Derdemezi J, Yuan S, Sen A
Biochem J. 1986; 238(2):341-4.
PMID: 3026349
PMC: 1147141.
DOI: 10.1042/bj2380341.
Partial characterization of an endogenous factor which modulates the effect of catecholamines on synaptosomal Na+, K+-ATPase.
Rodriguez de Lores Arnaiz G, Antonelli de Gomez de Lima M
Neurochem Res. 1986; 11(7):933-47.
PMID: 3018605
DOI: 10.1007/BF00965584.
Blood pressure in essential hypertension correlates with the concentration of a circulating inhibitor of the sodium pump.
Moreth K, Kuske R, Renner D, Schoner W
Klin Wochenschr. 1986; 64(5):239-44.
PMID: 3009961
DOI: 10.1007/BF01711656.
Dissociation of digoxin-like immunoreactivity and Na+,K+-ATPase inhibitory activity in rat plasma.
Yamada K, Goto A, Ishii M, Yoshioka M, Sugimoto T
Experientia. 1988; 44(11-12):992-3.
PMID: 2848712
DOI: 10.1007/BF01939897.
Different properties of two brain extracts separated in Sephadex G-50 that modify synaptosomal ATPase activities.
Rodriguez de Lores Arnaiz G, Antonelli de Gomez de Lima M, Girardi E
Neurochem Res. 1988; 13(3):229-35.
PMID: 2455236
DOI: 10.1007/BF00971538.
Effect of tissue specificity of brain soluble fractions on Na+, K(+)-ATPase activity.
Rodriguez de Lores Arnaiz G
Neurochem Res. 1990; 15(3):289-94.
PMID: 2164167
DOI: 10.1007/BF00968674.
In search of synaptosomal Na+,K(+)-ATPase regulators.
Rodriguez de Lores Arnaiz G
Mol Neurobiol. 1992; 6(4):359-75.
PMID: 1363048
DOI: 10.1007/BF02757941.
Endogenous factors with immunological and biological activity similar to cardiac glycosides: biochemical and pathophysiological implications.
Clerico A, Mariani G
J Endocrinol Invest. 1992; 15(5):397-416.
PMID: 1324267
DOI: 10.1007/BF03348763.
